ABOS Earning Date, Earning Analysis and Earning Prediction

Quarterly Results

ABOS Earnings Forecast

RevenueEPS

Currency: USD

Revenue Estimate-:0

EPS Estimate-:0

—

Stock Price0

Stock Price

Go Up

+51.61%

In Past 3 Month

Earnings Forecast

Revenue

EPS

Currency:

No data

Actual

Estimate

AI Analysis

Earnings Surprise Analysis

Revenue

EPS

AI Analysis

Earnings Reaction

The chart below shows how ABOS performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ABOS sees a 1.63% change in stock price 10 days leading up to the earnings, and a -2.67% change 10 days following the report. On the earnings day itself, the stock moves by 2.5%. This data can give you a slight idea of what to expect for the next quarter's release.

For example, in SEP/2025, the stock changed -7.18% on the day following the earnings release and then changed by 0% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.

People Also Watch

Frequently Asked Questions

What were the key highlights of ABOS's latest earnings report for FY2025Q3?

ABOS reported its FY2025Q3 earnings on 2025-11-12, showcasing a revenue of 0.00 against an estimate of , resulting in a 0% surprise. The EPS was -0.44, surpassing the expected -0.63 by 30.16%. The stock experienced a -1.02% price change on the earnings day and a -19.8% change over the next five days, reflecting market reactions to the results.

How did ABOS's stock price react after the FY2025Q3 earnings release?

Following ABOS's FY2025Q3 earnings announcement on 2025-11-12, the stock price moved by -1.02% on the day of the release. Over the subsequent five days, it saw a -19.8% change. Historically, ABOS's stock price tends to shift by an average of 1.63% in the 10 days leading up to earnings and -2.67% in the 10 days following, providing insight into potential market.

What are the revenue and EPS estimates for ABOS for ?

For , analysts estimate ABOS's annual revenue to reach undefined, while the EPS is projected at -0.38. These estimates reflect recent revisions, with revenue estimates revised upward by 51.61% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

How does ABOS's stock price correlate with earnings forecast revisions?

The correlation between ABOS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for were revised upward by 51.61%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

What should investors expect from ABOS's next earnings report?

Based on historical trends, ABOS's stock price typically moves by 1.63% in the 10 days before its earnings and -2.67% in the 10 days after. For the upcoming earnings, analysts expect an EPS of -0.38 and revenue of undefined.

What is the sentiment in Acumen Pharmaceuticals Inc (ABOS) Q4 2025 Earnings Call Summary?

The earnings call summary indicates strong preclinical results for the EBD program, showing significant improvements in brain exposure and distribution. The Q&A session reveals confidence in the program's efficacy and plans for presenting more data, which should positively impact investor sentiment. Although management avoided some direct comparisons, the overall tone is optimistic, especially with the planned expansion of trials and potential advantages over existing treatments. This suggests a likely positive stock price movement, despite the lack of specific market cap data.